Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

World IBS Day - April 19th: Raising Awareness for IBS Sufferers
  • USA - English


News provided by

World IBS Day

Mar 30, 2023, 11:16 ET

Share this article

Share toX

Share this article

Share toX

April 19th is World IBS Day. Help raise awareness this April 19th by using #WorldIBSDay2023
April 19th is World IBS Day. Help raise awareness this April 19th by using #WorldIBSDay2023

TORONTO, CANADA (PRWEB) March 30, 2023 -- Irritable Bowel Syndrome (IBS) is often stigmatized and misunderstood with symptoms significantly impacting the quality of life for many patients. World IBS Day on April 19th with the support of QOL Medical - CSID will join patients, family members, healthcare professionals and industry to increase awareness about IBS. Irritable Bowel Syndrome is a common digestive disorder which can significantly impair a patient’s quality of life due to its recurring episodes of abdominal pain, discomfort and bowel changes in diarrhea or constipation.

"World IBS Day was established to take place every year on April 19th to raise awareness about Irritable Bowel Syndrome by reducing stigma and supporting both patients and those that care for them."

Post this

This year’s theme for World IBS Day is The IBS Experience: IBS Chat through a Patient video. A video montage in the patient’s own voice submitted via the World IBS Day website (worldibsday.org), will be part of a free patient webinar event on World IBS Day as well as shown at Digestive Disease Week in May in Chicago, Illinois to illustrate the patient journey with IBS. Patients can sign up for the free April 19th webinar at tinyurl.com/WorldIBSDay. Additional events can be found on the World IBS Day website. We also ask everyone to use the hashtag #WorldIBSDay2023 to help raise awareness on April 19th.

World IBS Day is supported by Partners and friends from Australia, Austria, Canada, Denmark, France, Germany, India, Ireland, Italy, Malaysia, Netherlands, Norway, United Kingdom, and United States. Organizations, institutions, vendors and industry involvement are invited to add their events and support. World IBS Day social banners are available to download.

“We are happy to support World IBS Day in their effort to reassure patients that they are not alone. Empowering patients is one of our priorities. We encourage people to ask their healthcare provider a lot of questions when discussing their symptoms. Sometimes, arriving at a proper diagnosis begins with a simple question, "Could it be...? Congenital Sucrase-Isomaltase Deficiency (C-S-I-D), is a rare and often misdiagnosed disease. CSID symptoms look a lot like IBS. We hope that by joining forces we can provide awareness, resources, support, and education to patients." Anthony DElia, VP Marketing, QOL Medical.

Jeffrey Roberts, Founder of World IBS Day and IBS Patient Support Group stated that, “World IBS Day was established to take place every year on April 19th to raise awareness about Irritable Bowel Syndrome by reducing stigma and supporting both patients and those that care for them. We are grateful to add QOL Medical – CSID as our Lead Partner for 2023 so we can highlight the IBS mimicker of Congenital Sucrase-Isomaltase Deficiency (CSID). We want patients to understand that other conditions can also explain their symptoms.”

We are also thankful for the support from our 2023 Fellow Partners of Ardelyx, Ironwood, Mahana Therapeutics, metaMe Health, Salix Pharmaceuticals, Schär, For a Digestive Piece of Mind, and Tuesday Night IBS.

About Jeffrey Roberts, and the IBS Patient Support Group:

The IBS Patient Support Group was established by Jeffrey Roberts who was the founder of the first Irritable Bowel Syndrome patient community website in 1995. The IBS Patient Support Group community was launched as a public education advocacy community for sufferers and believes in evidenced-based medicine and non-anecdotal treatment options for patients. Jeffrey Roberts has been an Irritable Bowel Syndrome sufferer for over 25+ years and has worked closely with researchers, industry and patients for over 30 years. Visit https://www.ibspatient.org

About QOL Medical – Could It Be CSID:

QOL Medical is a specialty biopharmaceutical company dedicated to improving each patient’s life. They focus on solving complex, rare disease challenges with elegant solutions and want to change the world, one patient at a time. QOL Medical is focused on the treatment of Congenital Sucrase-Isomaltase Deficiency (CSID).

Jeffrey Roberts MED, Founder, World IBS Day, https://worldibsday.org, 1 2034240660, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.